IP Library Granted Patent US 8,507,213
Granted Patent B1
US 8,507,213 · App. 11/594,160 · Granted Aug 13, 2013

Methods and compositions for treating diseases targeting maba

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,507,213
App. No.
11/594,160
Granted
Aug 13, 2013
Kind
B1
Abstract

Methods and compositions for detecting and treating a disease, particularly cancer, associated with differential expression of Maba in disease cells compared to healthy cells. Also provided are antagonists or agonists of Maba, and methods for screening agents that modulate the Maba level or activity in vivo or in vitro.

Claims (3)

1. A method of diagnosing melanoma in an individual, the method comprising detecting the level of Maba protein in a skin sample from the individual and diagnosing said individual as having melanoma when the level is elevated relative to a control Maba protein level established for normal skin, wherein the Maba protein comprises SEQ ID NO:2.

2. The method of claim 1 , wherein the detecting comprises contacting the sample with an isolated antibody that selectively binds to the Maba protein and detecting binding of the antibody to the Maba protein.

3. The method of claim 2 , wherein the antibody is coupled to a detectable substance.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2008
From: APPLERA CORPORATION
To: CELERA CORPORATION
Reel/Frame 021561/0124 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2007
From: LEE, CANDY; DOMON, BRUNO; BIRSE, CHARLES E.; RUBEN, STEVE
To: APPLERA CORPORATION
Reel/Frame 018840/0866 →